Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
SN BIOSCIENCE
SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101’
May 14, 2026
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug ‘SNB-101’ on Gastric Cancer.
December 23, 2025